Life Science and Healthcare Investing in 2019

Get insight on INN Investor's Report on life science and healthcare investing. (You’ll also get our life science investing newsletter plus Life Science Investor Kits and email updates from select companies!*).

Enter your email below for instant access:

Privacy & legal information.
This report is free. No credit card required.

Life Science And Healthcare Investing in 2019:

Life Science Investing News has compiled this informative, insightful look at the exciting world of investing in life science companies in 2019. In genomics, pharmaceuticals, longevity and medical devices, the potential for 2019 is nothing short of revolutionary.

Contents

  • Biotech Trends 2018: Immuno-oncology Disappoints
  • Biotech Outlook 2019: Will the Pressure Continue?
  • Pharma Trends 2018: Drug Pricing Takes Center Stage
  • Pharma Outlook 2019: Drug Pricing Dialogue Continues
  • Medical Device Trends 2018: M&A, Tech and Regulatory Impact
  • Medical Device Outlook 2019: Fees Continue to Rise
  • Genetics Outlook 2019: CRISPR Technology Advances
Life Science and Healthcare Investing in 2019

Get insight and perspective in this INN Investor's Report on life science and healthcare investing. (You’ll also get our life science investing newsletter plus Life Science Investor Kits and email updates from select companies!*).

Enter your email below for instant access:

Privacy & legal information.
This report is free. No credit card required.

*Your free Life Science Investor Kits include:

  • Lexaria Bioscience
  • Cannara
  • Therma Bright Inc.
  • RISE Life Science
  • Kalytera Therapeutics
  • Cardiol Therapeutics
  • Aura Health
  • Canntab Therapeutics
  • BriaCell
  • MediPharm Labs

By completing this form, you are giving consent to receive email from the companies listed. And remember you can unsubscribe at any time.

Leave a Reply

Your email address will not be published. Required fields are marked *